SAT KARTAR LIFE LIMITED Fair Value
SATKARTAR · Healthcare · Current price ₹121.45
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹77 | 25% ROE fading to 12% over ~10 yrs, on ₹43 book |
| Relative P/E | ₹332 | EPS × 30.3 peer-median P/E |
| Graham floor | ₹103 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is SAT KARTAR LIFE LIMITED undervalued?
DocStoX estimates the fair value of SAT KARTAR LIFE LIMITED at ₹153 per share, versus the current market price of ₹121. That puts the stock about +25.8% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹77), Relative P/E (₹332), Graham floor (₹103). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹77 (bear) to ₹153 (base) to ₹332 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SAT KARTAR LIFE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.